PT1451182E - Compostos diméricos e sua utilização como agentes antivirais - Google Patents
Compostos diméricos e sua utilização como agentes antivirais Download PDFInfo
- Publication number
- PT1451182E PT1451182E PT02774166T PT02774166T PT1451182E PT 1451182 E PT1451182 E PT 1451182E PT 02774166 T PT02774166 T PT 02774166T PT 02774166 T PT02774166 T PT 02774166T PT 1451182 E PT1451182 E PT 1451182E
- Authority
- PT
- Portugal
- Prior art keywords
- viral agents
- dimeric compounds
- dimeric
- compounds
- orthomyxovirus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR8798A AUPR879801A0 (en) | 2001-11-09 | 2001-11-09 | Novel chemical compounds and their use |
AUPS2600A AUPS260002A0 (en) | 2002-05-27 | 2002-05-27 | Novel chemical compounds and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1451182E true PT1451182E (pt) | 2008-09-17 |
Family
ID=25646840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT02774166T PT1451182E (pt) | 2001-11-09 | 2002-11-08 | Compostos diméricos e sua utilização como agentes antivirais |
Country Status (13)
Country | Link |
---|---|
US (2) | US7157494B2 (pt) |
EP (1) | EP1451182B1 (pt) |
JP (2) | JP5183853B2 (pt) |
KR (1) | KR100942492B1 (pt) |
CN (1) | CN1285591C (pt) |
AT (1) | ATE398122T1 (pt) |
CA (1) | CA2462337C (pt) |
DE (1) | DE60227100D1 (pt) |
DK (1) | DK1451182T3 (pt) |
ES (1) | ES2305300T3 (pt) |
HK (1) | HK1068346A1 (pt) |
PT (1) | PT1451182E (pt) |
WO (1) | WO2003040135A1 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2305300T3 (es) * | 2001-11-09 | 2008-11-01 | Biota Scientific Management Pty. Ltd. | Compuestos dimericos y su utilizacion como agentes antiviricos. |
US7314949B2 (en) | 2004-12-04 | 2008-01-01 | Xerox Corporation | Trans-1,2-cyclohexane bis(urea-urethane) compounds |
US7317122B2 (en) | 2004-12-04 | 2008-01-08 | Xerox Corporation | Curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
US7220300B2 (en) | 2004-12-04 | 2007-05-22 | Xerox Corporation | Phase change inks containing bis(urea-urethane) compounds |
US7144450B2 (en) | 2004-12-04 | 2006-12-05 | Xerox Corporation | Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds |
US7560587B2 (en) | 2004-12-04 | 2009-07-14 | Xerox Corporation | Bis[urea-urethane] compounds |
US7576235B2 (en) | 2004-12-04 | 2009-08-18 | Xerox Corporation | Processes for preparing bis(urea-urethane) compounds |
US7153349B2 (en) | 2004-12-04 | 2006-12-26 | Xerox Corporation | Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
CN100471848C (zh) * | 2006-06-05 | 2009-03-25 | 中国医学科学院医药生物技术研究所 | 一组长链烷氧烷基取代唾液酸衍生物及其制备方法 |
CN108003065B (zh) * | 2016-10-27 | 2021-01-08 | 中国石油化工股份有限公司 | 一种具有增稠作用的化合物和润滑脂以及它们的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9516276D0 (en) * | 1995-08-08 | 1995-10-11 | Biota Scient Management | Chemical compounds |
HU223099B1 (hu) * | 1996-03-01 | 2004-03-29 | Biota Scientific Managemant Pty. Ltd. | Eljárás influenzavírus kimutatására és az eljárásban alkalmazható vegyületek |
US6153442A (en) * | 1998-05-20 | 2000-11-28 | Dade Behring Inc. | Reagents and methods for specific binding assays |
AUPP913999A0 (en) * | 1999-03-12 | 1999-04-01 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
AUPR001000A0 (en) | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
ES2305300T3 (es) * | 2001-11-09 | 2008-11-01 | Biota Scientific Management Pty. Ltd. | Compuestos dimericos y su utilizacion como agentes antiviricos. |
JP2010027130A (ja) | 2008-07-17 | 2010-02-04 | Sony Corp | 装着機構および出力装置 |
-
2002
- 2002-11-08 ES ES02774166T patent/ES2305300T3/es not_active Expired - Lifetime
- 2002-11-08 AT AT02774166T patent/ATE398122T1/de not_active IP Right Cessation
- 2002-11-08 DE DE60227100T patent/DE60227100D1/de not_active Expired - Lifetime
- 2002-11-08 KR KR1020047006444A patent/KR100942492B1/ko not_active IP Right Cessation
- 2002-11-08 CN CNB028222474A patent/CN1285591C/zh not_active Expired - Fee Related
- 2002-11-08 DK DK02774166T patent/DK1451182T3/da active
- 2002-11-08 WO PCT/AU2002/001524 patent/WO2003040135A1/en active IP Right Grant
- 2002-11-08 PT PT02774166T patent/PT1451182E/pt unknown
- 2002-11-08 US US10/494,243 patent/US7157494B2/en not_active Expired - Fee Related
- 2002-11-08 EP EP02774166A patent/EP1451182B1/en not_active Expired - Lifetime
- 2002-11-08 JP JP2003542181A patent/JP5183853B2/ja not_active Expired - Fee Related
- 2002-11-08 CA CA2462337A patent/CA2462337C/en not_active Expired - Fee Related
-
2005
- 2005-01-20 HK HK05100552A patent/HK1068346A1/xx not_active IP Right Cessation
-
2006
- 2006-12-04 US US11/607,872 patent/US20070293564A1/en not_active Abandoned
-
2010
- 2010-07-16 JP JP2010161587A patent/JP2010270130A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2010270130A (ja) | 2010-12-02 |
DE60227100D1 (de) | 2008-07-24 |
ATE398122T1 (de) | 2008-07-15 |
KR20050044337A (ko) | 2005-05-12 |
DK1451182T3 (da) | 2008-10-27 |
EP1451182B1 (en) | 2008-06-11 |
EP1451182A4 (en) | 2005-02-02 |
JP5183853B2 (ja) | 2013-04-17 |
US20050038108A1 (en) | 2005-02-17 |
CN1285591C (zh) | 2006-11-22 |
HK1068346A1 (en) | 2005-04-29 |
WO2003040135A1 (en) | 2003-05-15 |
CA2462337C (en) | 2011-09-27 |
US20070293564A1 (en) | 2007-12-20 |
CN1585765A (zh) | 2005-02-23 |
EP1451182A1 (en) | 2004-09-01 |
ES2305300T3 (es) | 2008-11-01 |
US7157494B2 (en) | 2007-01-02 |
CA2462337A1 (en) | 2003-05-15 |
JP2005510519A (ja) | 2005-04-21 |
KR100942492B1 (ko) | 2010-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1068346A1 (en) | Dimeric compounds and their use as anti-viral agents | |
CY1106522T1 (el) | Ετepοκυκλικη ενωση και αντικαρκινικο μεσο που πepιεχει την ιδια ως δραστικο συστατικο | |
MXPA04012965A (es) | Inhibidores virales. | |
IL175409A0 (en) | Oxazolidinone-quinolone hybrid derivatives and pharmaceutical compositions containing the same | |
AU3413100A (en) | Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase | |
UY29007A1 (es) | Derivados de 2-carbamida-4-feniltiazol, su preparacinn, y su aplicacinn en terapcutica | |
DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
DE60130023D1 (de) | Behandlung der nebenwirkungen von statinen | |
CY1108367T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
CY1109245T1 (el) | Ενωσεις χρησιμες στην θεραπεια ανθρακα και στην αναστολη θανατηφορου παραγοντα | |
EP1340755A4 (en) | AGENT WITH EFFECT AGAINST HELICOBACTER | |
MXPA06012566A (es) | Tratamiento de enfermedades infecciosas. | |
WO2005046672A3 (fr) | Utilisation d’inhibiteurs de glucosidase pour une therapie de la mucoviscidose | |
NO20033959L (no) | Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon | |
SG162614A1 (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors | |
BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
SE0004101D0 (sv) | New use | |
MXPA05006889A (es) | Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos. | |
MY139228A (en) | Imidazolinylmethyl aralkylsulfonamides | |
EE200800065A (et) | Prasoloprimidinoonhendit sisaldav toimeaine eesnrmesuurenemuse rahoidmiseks ja raviks | |
PT1059845E (pt) | Composicao fungicida compreendendo uma benzoilfenilureia | |
MXPA04002640A (es) | Esteres de analogos de 3-desoxi-vitamina d3. | |
TW200508208A (en) | Novel compound of 6-methyl-3-phenethyl-3,4-dihydro-1H-quinazoline-2-thione, its preparation and a depigmentation composition containing the same as an effective component | |
PL1610785T3 (pl) | Połączenie farmaceutyczne do leczenia spastyczności i/lub bólu | |
MY138183A (en) | Use of a compound for preventing and treating inflammation, ulcer, anaphylactic shock and hyperalgesia |